| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $58.4M | — | -6.9% |
| R&D Expense | $14.7M | — | +7.7% |
| SG&A Expense | $9.4M | — | -20.4% |
| Operating Income | -$13.3M | — | -385.4% |
| Pre-tax Income | -$10.1M | — | -297.6% |
| Income Tax | $610K | — | +75.3% |
| Net Income | -$10.7M | — | -270.7% |
| EPS (Basic) | -$0.08 | — | -300.0% |
| EPS (Diluted) | -$0.08 | — | -300.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $103.7M | -1.2% | -3.2% |
| Accounts Receivable | $21.7M | -1.5% | -13.5% |
| Current Assets | $133.9M | -0.7% | -8.0% |
| Total Assets | $282.4M | -2.8% | -10.0% |
| Current Liabilities | $44.1M | +2.0% | +9.1% |
| Total Liabilities | $63.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.7M | — | +12.7% |
| Capital Expenditures | $66K | — | -44.1% |
| Investing Cash Flow | -$4.1M | — | -14.1% |
| Financing Cash Flow | -$725K | — | +70.5% |
| Free Cash Flow | $3.7M | — | +14.8% |
| -9.5% |
| Stockholders' Equity | $219.3M | -3.7% | -10.1% |